A Phase 1 Dose Escalation Study of VX-993 in Healthy Participants

NCT05653323 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: VX-993
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated